Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)

PSA screening reduces PCa-mortality but the disadvantages overdiagnosis and overtreatment require multivariable risk-prediction tools to select appropriate treatment or active surveillance. This review explains the differences between the two largest screening trials and discusses the drawbacks of s...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:EJIFCC
Huvudupphovsmän: Stephan, Carsten, Rittenhouse, Harry, Hu, Xinhai, Cammann, Henning, Jung, Klaus
Materialtyp: Artigo
Språk:Inglês
Publicerad: The Communications and Publications Division (CPD) of the IFCC 2014
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4975191/
https://ncbi.nlm.nih.gov/pubmed/27683457
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk